117 related articles for article (PubMed ID: 32248342)
1. Identification of an AP1-ZFP36 Regulatory Network Associated with Breast Cancer Prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract][Full Text] [Related]
2. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
3. Mammary differentiation induces expression of Tristetraprolin, a tumor suppressor AU-rich mRNA-binding protein.
Goddio MV; Gattelli A; Slomiansky V; Lacunza E; Gingerich T; Tocci JM; Facchinetti MM; Curino AC; LaMarre J; Abba MC; Kordon EC
Breast Cancer Res Treat; 2012 Oct; 135(3):749-58. PubMed ID: 22968621
[TBL] [Abstract][Full Text] [Related]
4. Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS.
Shah S; Mostafa MM; McWhae A; Traves SL; Newton R
J Biol Chem; 2016 Jan; 291(1):110-25. PubMed ID: 26546680
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA 000554 represses epithelial-mesenchymal transition in breast cancer by regulating microRNA-182/ZFP36 axis.
Mao Y; Lv M; Cao W; Liu X; Cui J; Wang Y; Wang Y; Nie G; Liu X; Wang H
FASEB J; 2020 Sep; 34(9):11405-11420. PubMed ID: 32729957
[TBL] [Abstract][Full Text] [Related]
6. CREB targets define the gene expression signature of malignancies having reduced levels of the tumor suppressor tristetraprolin.
Fallahi M; Amelio AL; Cleveland JL; Rounbehler RJ
PLoS One; 2014; 9(12):e115517. PubMed ID: 25541715
[TBL] [Abstract][Full Text] [Related]
7. A synonymous polymorphism of the Tristetraprolin (TTP) gene, an AU-rich mRNA-binding protein, affects translation efficiency and response to Herceptin treatment in breast cancer patients.
Griseri P; Bourcier C; Hieblot C; Essafi-Benkhadir K; Chamorey E; Touriol C; Pagès G
Hum Mol Genet; 2011 Dec; 20(23):4556-68. PubMed ID: 21875902
[TBL] [Abstract][Full Text] [Related]
8. Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.
Gutzman JH; Rugowski DE; Schroeder MD; Watters JJ; Schuler LA
Mol Endocrinol; 2004 Dec; 18(12):3064-75. PubMed ID: 15319452
[TBL] [Abstract][Full Text] [Related]
9. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
Hachim IY; Shams A; Lebrun JJ; Ali S
Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in RNA binding proteins contribute to breast cancer survival.
Upadhyay R; Sanduja S; Kaza V; Dixon DA
Int J Cancer; 2013 Feb; 132(3):E128-38. PubMed ID: 22907529
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
12. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract][Full Text] [Related]
13. Estrogen stimulates transcription from the human prolactin distal promoter through AP1 and estrogen responsive elements in T47D human breast cancer cells.
Duan R; Ginsburg E; Vonderhaar BK
Mol Cell Endocrinol; 2008 Jan; 281(1-2):9-18. PubMed ID: 18022314
[TBL] [Abstract][Full Text] [Related]
14. Wnt/CTNNB1 Signal Transduction Pathway Inhibits the Expression of ZFP36 in Squamous Cell Carcinoma, by Inducing Transcriptional Repressors SNAI1, SLUG and TWIST.
Zanfi ED; Fantini S; Lotti R; Bertesi M; Marconi A; Grande A; Manfredini R; Pincelli C; Zanocco-Marani T
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784485
[TBL] [Abstract][Full Text] [Related]
15. Global target mRNA specification and regulation by the RNA-binding protein ZFP36.
Mukherjee N; Jacobs NC; Hafner M; Kennington EA; Nusbaum JD; Tuschl T; Blackshear PJ; Ohler U
Genome Biol; 2014 Jan; 15(1):R12. PubMed ID: 24401661
[TBL] [Abstract][Full Text] [Related]
16. Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.
Tu Y; Wu X; Yu F; Dang J; Wang J; Wei Y; Cai Z; Zhou Z; Liao W; Li L; Zhang Y
BMC Immunol; 2019 May; 20(1):13. PubMed ID: 31046669
[TBL] [Abstract][Full Text] [Related]
17. Possible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen.
Altundag K; Altundag O; Gunduz M; Arun B
Med Hypotheses; 2004; 63(5):823-6. PubMed ID: 15488654
[TBL] [Abstract][Full Text] [Related]
18. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
19. EGF activates TTP expression by activation of ELK-1 and EGR-1 transcription factors.
Florkowska M; Tymoszuk P; Balwierz A; Skucha A; Kochan J; Wawro M; Stalinska K; Kasza A
BMC Mol Biol; 2012 Mar; 13():8. PubMed ID: 22433566
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin mediates the anti-proliferative effects of metformin in breast cancer cells.
Pandiri I; Chen Y; Joe Y; Kim HJ; Park J; Chung HT; Park JW
Breast Cancer Res Treat; 2016 Feb; 156(1):57-64. PubMed ID: 26956973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
